NDC Package 51754-6015-3 Glyrx-pf

Glycopyrrolate Injection, Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51754-6015-3
Package Description:
10 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC
Product Code:
Proprietary Name:
Glyrx-pf
Non-Proprietary Name:
Glycopyrrolate
Substance Name:
Glycopyrrolate
Usage Information:
Glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This medication works by decreasing the amount of saliva you make. Glycopyrrolate belongs to a class of drugs known as anticholinergics.
11-Digit NDC Billing Format:
51754601503
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1731582 - glycopyrrolate 0.2 MG in 1 ML Injection
  • RxCUI: 1731582 - 1 ML glycopyrrolate 0.2 MG/ML Injection
  • RxCUI: 1731582 - glycopyrrolate 0.2 MG per 1 ML Injection
  • RxCUI: 1731590 - glycopyrrolate 0.4 MG in 2 ML Injection
  • RxCUI: 1731590 - 2 ML glycopyrrolate 0.2 MG/ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Exela Pharma Sciences, Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA210997
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-01-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51754-6015-3?

    The NDC Packaged Code 51754-6015-3 is assigned to a package of 10 syringe, plastic in 1 carton / 5 ml in 1 syringe, plastic of Glyrx-pf, a human prescription drug labeled by Exela Pharma Sciences, Llc. The product's dosage form is injection, solution and is administered via intramuscular; intravenous form.

    Is NDC 51754-6015 included in the NDC Directory?

    Yes, Glyrx-pf with product code 51754-6015 is active and included in the NDC Directory. The product was first marketed by Exela Pharma Sciences, Llc on June 01, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51754-6015-3?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 51754-6015-3?

    The 11-digit format is 51754601503. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151754-6015-35-4-251754-6015-03